Lincoln National Corp Haleon PLC Transaction History

Lincoln National Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$8.02 - $8.67 $83,295 - $90,046	10,386 Added 57.98%	28,299 $240,000
Q4 2023 Feb 06, 2024	SELL	$7.78 - $8.62 $357 - $396	-46 Reduced 0.26%	17,913 $147,000
Q3 2023 Nov 03, 2023	SELL	$7.85 - $8.94 $11,775 - $13,410	-1,500 Reduced 7.71%	17,959 $149,000
Q2 2023 Aug 04, 2023	BUY	$8.04 - $9.0 $54,760 - $61,299	6,811 Added 53.85%	19,459 $163,000
Q1 2023 May 01, 2023	BUY	$7.57 - $8.37 $105 - $117	14 Added 0.11%	12,648 $102,000
Q4 2022 Feb 07, 2023	BUY	$5.96 - $8.06 $1,174 - $1,587	197 Added 1.58%	12,634 $101,000
Q3 2022 Nov 03, 2022	BUY	$5.63 - $7.5 $70,020 - $93,277	12,437 New	12,437 $75,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.